Table 1.
Genetic correlation between female-specific cancers and COVID-19 phenotypes
| Cancer | COVID-19 phenotype | 95%CI | p-value | |
|---|---|---|---|---|
| BC | Infection | −0.01 | (-0.09,0.08) | 0.90 |
| Hospitalization | 0.06 | (-0.02,0.14) | 0.16 | |
| Critical illness | 0.05 | (-0.04,0.13) | 0.28 | |
| EOC | Infection | 0.01 | (-0.16,0.18) | 0.91 |
| Hospitalization | −0.04 | (-0.19,0.10) | 0.55 | |
| Critical illness | −0.02 | (-0.17,0.13) | 0.77 | |
| EC | Infection | 0.09 | (-0.06,0.24) | 0.23 |
| Hospitalization | 0.19 | (0.04,0.34) | 0.01 | |
| Critical illness | 0.29 | (0.14,0.45) | 3.00 × 10−4∗ |
Bold-face: p < 0.05; ∗p < 5.56 × 10−3.
: genetic correlation; CI: confidence interval; Infection: reported SARS-CoV-2 infection vs. population; Hospitalization: COVID-19 hospitalization patients vs. population; Critical illness: very severe respiratory confirmed COVID-19 patients vs. population; BC: breast cancer; EOC: overall invasive epithelial ovarian cancer; EC: endometrial cancer.